Whitney Wolf

1.5k total citations
12 papers, 243 citations indexed

About

Whitney Wolf is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Whitney Wolf has authored 12 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Whitney Wolf's work include Respiratory viral infections research (4 papers), Cystic Fibrosis Research Advances (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Whitney Wolf is often cited by papers focused on Respiratory viral infections research (4 papers), Cystic Fibrosis Research Advances (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Whitney Wolf collaborates with scholars based in United States, Canada and United Kingdom. Whitney Wolf's co-authors include Michael R. Knowles, Margaret Rosenfeld, Maimoona A. Zariwala, Margaret W. Leigh, Adam J. Shapiro, Scott D. Sagel, Johnny L. Carson, Kenneth N. Olivier, Sharon Dell and Carlos Milla and has published in prestigious journals such as CHEST Journal, The American Journal of Human Genetics and Frontiers in Immunology.

In The Last Decade

Whitney Wolf

12 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Whitney Wolf United States	5	172	82	61	60	31	12	243
T. Frischer Austria	6	235 1.4×	68 0.8×	30 0.5×	30 0.5×	17 0.5×	9	275
Thomas Nüßlein Germany	3	134 0.8×	137 1.7×	73 1.2×	18 0.3×	20 0.6×	6	225
Rahul Chodhari United Kingdom	3	220 1.3×	96 1.2×	43 0.7×	27 0.5×	27 0.9×	7	283
G Baktai Hungary	3	320 1.9×	83 1.0×	27 0.4×	37 0.6×	19 0.6×	3	359
Maha Al Dabbagh Saudi Arabia	4	97 0.6×	131 1.6×	119 2.0×	15 0.3×	12 0.4×	7	256
Brigitte Wulf Germany	6	311 1.8×	40 0.5×	45 0.7×	16 0.3×	17 0.5×	9	353
Jaime E. Hale United States	5	35 0.2×	27 0.3×	23 0.4×	18 0.3×	17 0.5×	6	104
Sofìa Kitsiou Greece	10	38 0.2×	155 1.9×	71 1.2×	11 0.2×	33 1.1×	25	260
Erica Schindewolf United States	7	26 0.2×	41 0.5×	63 1.0×	40 0.7×	43 1.4×	24	121
Caterina Tandoi Italy	4	72 0.4×	47 0.6×	126 2.1×	90 1.5×	36 1.2×	5	172

Countries citing papers authored by Whitney Wolf

Since Specialization

Citations

This map shows the geographic impact of Whitney Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Whitney Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Whitney Wolf more than expected).

Fields of papers citing papers by Whitney Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Whitney Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Whitney Wolf. The network helps show where Whitney Wolf may publish in the future.

Co-authorship network of co-authors of Whitney Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Whitney Wolf. A scholar is included among the top collaborators of Whitney Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Whitney Wolf. Whitney Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Shen, Limei, Alison Schaefer, Justin T. Huckaby, Whitney Wolf, & Samuel K. Lai. (2025). Bispecific Siglec-15/T cell antibody (STAB) activates T cells and suppresses pancreatic ductal adenocarcinoma and non-small cell lung tumors in vivo. Theranostics. 15(12). 5529–5542. 1 indexed citations

Tiruthani, Karthik, Jasper Fuk‐Woo Chan, Alice Ma, et al.. (2024). Engineering a “muco‐trapping” ACE2 ‐immunoglobulin hybrid with picomolar affinity as an inhaled, pan‐variant immunotherapy for COVID ‐19. Bioengineering & Translational Medicine. 9(4). e10650–e10650. 3 indexed citations

Shen, Limei, Alison Schaefer, Karthik Tiruthani, Whitney Wolf, & Samuel K. Lai. (2024). Siglec15/ TGF ‐β bispecific antibody mediates synergistic anti‐tumor response against 4T1 triple negative breast cancer in mice. Bioengineering & Translational Medicine. 9(5). e10651–e10651. 1 indexed citations

McSweeney, Morgan D., Alison Schaefer, Whitney Wolf, et al.. (2024). Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections. Advanced Science. 11(12). e2306729–e2306729. 8 indexed citations

Togami, Kohei, Whitney Wolf, Limei Shen, et al.. (2024). Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium. Frontiers in Immunology. 15. 1371156–1371156. 2 indexed citations

Cho, Junghyun, Ian E. Stewart, Karthik Tiruthani, et al.. (2023). Stable nebulization and muco-trapping properties of regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19. UNC Libraries. 2 indexed citations

McSweeney, Morgan D., Ian E. Stewart, Hyunah Kang, et al.. (2022). Stable nebulization and muco‐trapping properties of regdanvimab/ IN ‐006 support its development as a potent, dose‐saving inhaled therapy for COVID ‐19. Bioengineering & Translational Medicine. 8(1). e10391–e10391. 13 indexed citations

Carson, Johnny L., Michael R. Knowles, Kimberlie A. Burns, et al.. (2020). Laterality defects other than situs inversus totalis in primary ciliary dyskinesia: Insights into situs ambiguus and heterotaxy. UNC Libraries. 4 indexed citations

DeBrosse, Suzanne D., Steven Strausbaugh, Moira L. Aitken, et al.. (2019). The expanding phenotype of OFD1‐related disorders: Hemizygous loss‐of‐function variants in three patients with primary ciliary dyskinesia. Molecular Genetics & Genomic Medicine. 7(9). e911–e911. 39 indexed citations

10.

Leigh, Margaret W., Karen E. Weck, Ian King, et al.. (2018). The prevalence of the defining features of primary ciliary dyskinesia within a cri du chat syndrome cohort. Pediatric Pulmonology. 53(11). 1565–1573. 4 indexed citations

11.

O’Neal, Wanda K., Paul J. Gallins, Rhonda G. Pace, et al.. (2015). Gene Expression in Transformed Lymphocytes Reveals Variation in Endomembrane and HLA Pathways Modifying Cystic Fibrosis Pulmonary Phenotypes. The American Journal of Human Genetics. 96(2). 318–328. 22 indexed citations

12.

Shapiro, Adam J., Stephanie D. Davis, Thomas W. Ferkol, et al.. (2014). Laterality Defects Other Than Situs Inversus Totalis in Primary Ciliary Dyskinesia. CHEST Journal. 146(5). 1176–1186. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact